Parsons Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-61,050
| Closed | -$6.06M | – | 361 |
|
|
2019
Q3 | $6.06M | Sell |
61,050
-440
| -0.7% | -$41.8K | 0.66% | 31 |
|
|
2019
Q2 | $5.68M | Sell |
61,490
-475
| -0.8% | -$45.1K | 0.62% | 36 |
|
|
2019
Q1 | $5.85M | Buy |
61,965
+24,970
| +67% | +$2.18M | 0.64% | 34 |
|
|
2018
Q4 | $2.37M | Sell |
36,995
-4,001
| -10% | -$295K | 0.29% | 84 |
|
|
2018
Q3 | $3.67M | Sell |
40,996
-1,550
| -4% | -$137K | 0.39% | 63 |
|
|
2018
Q2 | $3.38M | Sell |
42,546
-1,346
| -3% | -$112K | 0.38% | 65 |
|
|
2018
Q1 | $3.92M | Sell |
43,892
-5,055
| -10% | -$485K | 0.46% | 52 |
|
|
2017
Q4 | $5.11M | Sell |
48,947
-1,515
| -3% | -$171K | 0.57% | 41 |
|
|
2017
Q3 | $7.36M | Buy |
50,462
+1,267
| +3% | +$173K | 0.87% | 22 |
|
|
2017
Q2 | $6.39M | Buy |
49,195
+185
| +0.4% | +$22.7K | 0.78% | 25 |
|
|
2017
Q1 | $6.1M | Sell |
49,010
-475
| -1% | -$56.8K | 0.77% | 29 |
|
|
2016
Q4 | $5.73M | Sell |
49,485
-440
| -0.9% | -$49K | 0.76% | 31 |
|
|
2016
Q3 | $5.22M | Sell |
49,925
-990
| -2% | -$107K | 0.7% | 35 |
|
|
2016
Q2 | $5.02M | Buy |
50,915
+1,475
| +3% | +$153K | 0.68% | 37 |
|
|
2016
Q1 | $4.95M | Sell |
49,440
-5,069
| -9% | -$522K | 0.68% | 38 |
|
|
2015
Q4 | $6.53M | Sell |
54,509
-505
| -0.9% | -$58.4K | 0.92% | 20 |
|
|
2015
Q3 | $5.95M | Buy |
55,014
+290
| +0.5% | +$36K | 0.87% | 20 |
|
|
2015
Q2 | $6.33M | Sell |
54,724
-721
| -1% | -$82.4K | 0.84% | 20 |
|
|
2015
Q1 | $6.39M | Buy |
55,445
+1,721
| +3% | +$206K | 0.9% | 18 |
|
|
2014
Q4 | $6.01M | Buy |
53,724
+799
| +2% | +$84.3K | 0.8% | 26 |
|
|
2014
Q3 | $5.01M | Buy |
52,925
+473
| +0.9% | +$42.7K | 0.69% | 32 |
|
|
2014
Q2 | $4.5M | Sell |
52,452
-1,066
| -2% | -$81.1K | 0.62% | 40 |
|
|
2014
Q1 | $3.73M | Sell |
53,518
-3,500
| -6% | -$277K | 0.53% | 48 |
|
|
2013
Q4 | $4.82M | Buy |
57,018
+1,018
| +2% | +$80.6K | 0.72% | 35 |
|
|
2013
Q3 | $4.32M | Sell |
56,000
-10,800
| -16% | -$757K | 0.71% | 35 |
|
|
2013
Q2 | $3.91M | Buy |
+66,800
| New | +$4.02M | 0.67% | 37 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Parsons Capital Management's CELG Position: Q4 2019 in Review
Parsons Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 61,050 shares — an estimated $6.06M sold.
Parsons Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.36M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Parsons Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Parsons Capital Management sold 61,050 Celgene Corp shares in Q4 2019, an estimated $6.06M.
- Parsons Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Parsons Capital Management's Celgene Corp position peaked at $7.36M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.